» Articles » PMID: 40002249

Colorectal Adenoma Subtypes Exhibit Signature Molecular Profiles: Unique Insights into the Microenvironment of Advanced Precancerous Lesions for Early Detection Applications

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2025 Feb 26
PMID 40002249
Authors
Affiliations
Soon will be listed here.
Abstract

: Colorectal cancer (CRC) is characterized by the uncontrolled growth of malignant colonic or rectal crypt epithelium. About 85% of CRCs evolve through a stepwise progression from advanced precancerous adenoma lesions. A better understanding of the evolution from adenoma to carcinoma can provide a window of opportunity not only for early detection and therapeutic intervention but potentially also for cancer prevention strategies. : This study investigates the heterogeneous methylation, copy-number alteration (CNA), and mutation signals of histological adenoma subtypes in the context of progression from normal colon to advanced precancerous lesions (APLs) and early-stage CRC. : Differential methylation analysis revealed 2321 significantly altered regions among APLs: 137 hypermethylated regions in serrated vs. tubular, 2093 in serrated vs. tubulovillous, and 91 in tubular vs. tubulovillous adenoma subtypes. The most differentiating pathways for serrated adenomas belonged to cAMP signaling and the regulation of pluripotency of stem cells, while regions separating tubular and tubulovillous subtypes were enriched for WNT signaling. CNA events were mostly present in tubular or tubulovillous adenomas, with the most frequent signals being seen in chromosomes 7, 12, 19, and 20. In contrast, early-stage CRC exhibited signals in chromosomes 7, 8, and 20, indicating different processes between APL and early-stage CRC. Mutations reinforce subtype-level differences, showing specific alterations in each subtype. : These findings are especially important for developing early detection or cancer prevention tests trying to capture adenoma signatures.

References
1.
Sun Y, Zhang X, Hang D, Lau H, Du J, Liu C . Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers. Cancer Cell. 2024; 42(8):1386-1400.e8. DOI: 10.1016/j.ccell.2024.07.005. View

2.
Fornasarig M, Magris R, De Re V, Bidoli E, Canzonieri V, Maiero S . Molecular and Pathological Features of Gastric Cancer in Lynch Syndrome and Familial Adenomatous Polyposis. Int J Mol Sci. 2018; 19(6). PMC: 6032275. DOI: 10.3390/ijms19061682. View

3.
Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I . Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3):229-263. DOI: 10.3322/caac.21834. View

4.
Galuppini F, Fassan M, Mastracci L, Gafa R, Lo Mele M, Lazzi S . The histomorphological and molecular landscape of colorectal adenomas and serrated lesions. Pathologica. 2021; 113(3):218-229. PMC: 8299322. DOI: 10.32074/1591-951X-270. View

5.
Osmond A, Li-Chang H, Kirsch R, Divaris D, Falck V, Liu D . Interobserver variability in assessing dysplasia and architecture in colorectal adenomas: a multicentre Canadian study. J Clin Pathol. 2014; 67(9):781-6. DOI: 10.1136/jclinpath-2014-202177. View